The New Phase 3 Numbers Here is the new July 23 data in plain language: TRIUMPH-2: 20.8% average weight loss at 80 weeks with 12 mg, plus A1C reductions up to 1.6 percentage points TRIUMPH-3: 22.6% average weight loss at 80 weeks with 12 mg The most common adverse events were gastrointestinal and generally mild to moderate Lilly plans to submit its BLA to the FDA in Q1 2027 The TRIUMPH-2 population had obesity or overweight plus type 2 diabetes, which makes the weight-loss result especially relevant because it came in a harder-to-treat metabolic group
More weight-loss medications are on the way
When it comes to reconstituting medications in healthcare facilities, the use of bacteriostatic water for injection is preferred, especially when multi-dosing is required
Certain foods are especially beneficial while taking Ozempic, like high-protein foods, whole grains, nuts, and legumes
However, because Wegovy slows gastric emptying, oral medicines such as levothyroxine should continue to be taken exactly as prescribed, typically on an empty stomach before breakfast
Patients who experience substantial weight loss or excellent glycemic control with minimal side effects are more likely to continue long-term therapy